艾德生物
(300685)
| 流通市值：89.30亿 | | | 总市值：89.74亿 |
| 流通股本：3.90亿 | | | 总股本：3.92亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 984,160,214.99 | 876,734,780.23 | 828,873,935.82 | 736,841,008.77 |
| 交易性金融资产 | 242,347,632.37 | 382,699,868.39 | 351,885,744.55 | 349,096,411.99 |
| 应收票据及应收账款 | 617,275,719.79 | 556,814,017.83 | 542,105,519.22 | 584,567,059.45 |
| 其中：应收票据 | 20,630,271.31 | 20,615,148.54 | 15,856,231.01 | 10,723,097.87 |
| 应收账款 | 596,645,448.48 | 536,198,869.29 | 526,249,288.21 | 573,843,961.58 |
| 预付款项 | 13,345,315.03 | 18,674,289.46 | 12,851,955.47 | 12,502,342.1 |
| 其他应收款合计 | 1,980,766.64 | 2,473,417.5 | 2,348,321.53 | 2,516,015.9 |
| 存货 | 41,873,616.88 | 34,636,347.03 | 34,365,482.01 | 37,320,993.03 |
| 合同资产 | 1,981,849.06 | 1,024,058.17 | 1,192,823.51 | 2,888,146.64 |
| 一年内到期的非流动资产 | 5,592,987.16 | 5,457,706.54 | 5,322,425.92 | 11,062,145.3 |
| 其他流动资产 | 11,451,428.05 | 12,907,401.49 | 9,453,688.74 | 6,312,142.46 |
| 流动资产合计 | 1,920,009,529.97 | 1,891,421,886.64 | 1,788,399,896.77 | 1,743,106,265.64 |
| 非流动资产: | | | | |
| 长期应收款 | 12,405,529.02 | 12,263,822.58 | 12,122,116.14 | 23,730,409.7 |
| 长期股权投资 | 10,950,220.1 | 10,497,291.81 | 11,951,810.18 | 20,574,590.68 |
| 固定资产 | 165,304,163.63 | 170,749,929.32 | 173,256,020.58 | 182,566,429.72 |
| 使用权资产 | 11,312,403.5 | 11,837,434.89 | 12,997,943.06 | 5,622,163.48 |
| 无形资产 | 43,478,998.79 | 45,285,167.34 | 43,582,741.36 | 45,347,653.38 |
| 长期待摊费用 | 3,052,122.69 | 3,524,161.46 | 4,736,367.84 | 4,429,784.24 |
| 递延所得税资产 | 11,148,052.24 | 11,064,822.26 | 10,060,623.33 | 8,417,345.15 |
| 其他非流动资产 | 16,161,736.68 | 6,868,313 | 7,694,191.8 | 1,800,378.6 |
| 非流动资产合计 | 273,813,226.65 | 272,090,942.66 | 276,401,814.29 | 292,488,754.95 |
| 资产总计 | 2,193,822,756.62 | 2,163,512,829.3 | 2,064,801,711.06 | 2,035,595,020.59 |
| 流动负债: | | | | |
| 短期借款 | 5,000,000 | - | - | 5,004,794.52 |
| 应付票据及应付账款 | 30,043,052.22 | 23,171,478.76 | 19,702,291.87 | 21,170,445.3 |
| 应付账款 | 30,043,052.22 | 23,171,478.76 | 19,702,291.87 | 21,170,445.3 |
| 预收款项 | 48,790 | - | 84,640 | 191,322.67 |
| 合同负债 | 2,936,803.16 | 3,669,048.13 | 4,281,980.76 | 5,647,775.41 |
| 应付职工薪酬 | 57,134,609.33 | 46,308,003.48 | 39,558,744.29 | 53,884,728.9 |
| 应交税费 | 43,930,240.04 | 42,724,154.59 | 25,332,940.67 | 18,377,317.04 |
| 其他应付款合计 | 81,242,785.44 | 54,358,251.52 | 57,290,286.04 | 64,032,500.57 |
| 应付股利 | 23,679,436.32 | - | - | - |
| 一年内到期的非流动负债 | 4,590,311.6 | 48,790,761.52 | 48,523,955.23 | 47,944,176.61 |
| 其他流动负债 | 98,581.63 | 178,849.05 | 47,739.86 | 65,903.68 |
| 流动负债合计 | 225,025,173.42 | 219,200,547.05 | 194,822,578.72 | 216,318,964.7 |
| 非流动负债: | | | | |
| 长期借款 | 58,832,876.71 | - | - | - |
| 租赁负债 | 8,487,149.67 | 7,837,091.1 | 8,732,314.17 | 2,737,297.34 |
| 递延收益 | 15,814,374.89 | 17,628,217.61 | 17,982,060.31 | 8,077,960.01 |
| 非流动负债合计 | 83,134,401.27 | 25,465,308.71 | 26,714,374.48 | 10,815,257.35 |
| 负债合计 | 308,159,574.69 | 244,665,855.76 | 221,536,953.2 | 227,134,222.05 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 391,536,144 | 393,061,969 | 398,436,809 | 398,540,309 |
| 资本公积 | 122,343,577.15 | 136,956,196.36 | 232,079,474.86 | 240,852,345.62 |
| 减:库存股 | 33,267,132.28 | 34,380,996.78 | 120,438,010.16 | 136,777,148.97 |
| 其他综合收益 | 2,199,060.22 | 2,045,483.62 | 2,142,884.84 | 2,404,126.02 |
| 盈余公积 | 149,842,444.59 | 149,842,444.59 | 149,842,444.59 | 128,577,301.26 |
| 未分配利润 | 1,253,009,088.25 | 1,271,321,876.75 | 1,181,201,154.73 | 1,174,863,865.61 |
| 归属于母公司股东权益合计 | 1,885,663,181.93 | 1,918,846,973.54 | 1,843,264,757.86 | 1,808,460,798.54 |
| 股东权益合计 | 1,885,663,181.93 | 1,918,846,973.54 | 1,843,264,757.86 | 1,808,460,798.54 |
| 负债和股东权益合计 | 2,193,822,756.62 | 2,163,512,829.3 | 2,064,801,711.06 | 2,035,595,020.59 |
| 公告日期 | 2025-07-29 | 2025-04-22 | 2025-04-22 | 2024-10-22 |
| 审计意见(境内) | | | 标准无保留意见 | |